RePEc Click here to visit UConn Economics IDEAS

This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

Research classified by Journal of Economic Literature (JEL) codes


Top JEL
/ L: Industrial Organization
/ / L6: Industry Studies: Manufacturing
/ / / L65: Chemicals; Rubber; Drugs; Biotechnology
This topic is covered by the following reading lists:
  1. Industrial Sociology (FCT-UNL)

Most recent items first, undated at the end.
  • 2009 Patenting activity in biotechnology and pharmaceuticals: a comparative analysis of the Nordic Countries
    by Enrico Sorisio [Downloadable!]
  • 2009 How variable is labor input in the Italian manufacturing: the case of the pharmaceutical industry
    by Lorenzo Carbonari & [Downloadable!]
  • 2009 Investments in Pharmaceuticals Before and After TRIPS
    by Margaret Kyle & Anita McGahan [Downloadable!]
  • 2009 Technology, Competition and the Time of Entry: Diversification Patterns in the Development of New Drugs
    by Tatiana Plotnikova [Downloadable!]
  • 2009 Technological Diversity and Future Product Diversity in the Drug Industry
    by Uwe Cantner & Tatiana Plotnikova [Downloadable!]
  • 2009 Evolution 1998-2002 of the antidepressant consumption in France, Germany and the United Kingdom
    by Nathalie Grandfils & Catherine Sermet [Downloadable!]
  • 2009 What’s on the Table? The Doha Round as of August 2009
    by Matthew Adler & Claire Brunel & Gary Clyde Hufbauer & Jeffrey J. Schott [Downloadable!]
  • 2009 Surgimiento de actividades de exportación exitosas en México: tres casos específicos
    by Edgar Aragon & Anne Fouquet & Marcia Campos [Downloadable!]
  • 2009 Surgimiento de actividades de exportación exitosas en Uruguay: cuatro casos específicos
    by Michele Snoeck & Lucia Pittaluga & Hector Pastori & Rosario Domingo & Carlos Casacuberta [Downloadable!]
  • 2009 The Emergence of Successful Export Activities in Uruguay: Four Case Studies
    by Michele Snoeck & Lucia Pittaluga & Hector Pastori & Rosario Domingo & Carlos Casacuberta [Downloadable!]
  • 2009 Surgimiento de nuevas actividades de exportación en América Latina: el caso de Chile
    by Manuel Agosin & Claudio Bravo-Ortega [Downloadable!]
  • 2009 The Emergence of New Successful Export Activities in Latin America: The Case of Chile
    by Manuel Agosin & Claudio Bravo-Ortega [Downloadable!]
  • 2009 The Emergence of Successful Export Activities in Mexico: Three Case Studies
    by Edgar Aragon & Anne Fouquet & Marcia Campos [Downloadable!]
  • 2009 Price and welfare effects of a pharmaceutical substitution reform
    by Granlund, David [Downloadable!]
  • 2009 Price and welfare effects of a pharmaceutical substitution reform
    by Granlund, David
  • 2009 How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French)
    by Matthieu MONTALBAN ( (GREThA UMR CNRS 5113) [Downloadable!]
  • 2009 How financialisation shapes productive models in pharmaceutical industry: the domination and contradictions of the blockbuster conception of control (In French)
    by Matthieu MONTALBAN (GREThA-GRES) [Downloadable!]
  • 2009 Entry in the ADHD drugs market: Welfare impact of generics and me-toos
    by Farasat A.S. Bokhari & Gary M. Fournier [Downloadable!]
  • 2009 On Pricing and Vertical Organization of Differentiated Products
    by Shi, Guanming & Chavas, Jean-Paul [Downloadable!]
  • 2009 ¿A quién beneficia el comercio paralelo de medicamentos en la Unión Europea?
    by Costa-Font, Joan & Kanavos, Panos
  • 2009 Small is beautiful: deutsche Chemieunternehmen schrumpfen sich produktiv
    by Oleg Badunenko [Downloadable!]
  • 2008 The Tunisian Pharmaceutical Sector in Transformation: Inventory of Fixtures and Innovation Prospects
    by Nejla Yacoub [Downloadable!]
  • 2008 Stratégies d’innovation des firmes des sciences de la vie et appropriation des ressources végétales : processus et enjeux Innovations strategies of firms in life science and appropriation of vegetal resources : process and stakes
    by Blandine Laperche [Downloadable!]
  • 2008 La lutte anti-blanchiment dans le secteur de l’assurance (the fight against money laundering in the insurance sector)
    by Éric Vernier & Hubert Delval [Downloadable!]
  • 2008 Consumer Learning and Heterogeneity: Dynamics of Demand for Prescription Drugs after Patent Expiration
    by Ching, Andrew [Downloadable!]
  • 2008 Firm dynamic governance of global innovation by means of flexible networks of connections
    by Gay, Brigitte [Downloadable!]
  • 2008 Overcoming Innovation Limits through Outward FDI: The Overseas Acquisition Strategy of Indian Pharmaceutical Firms
    by Pradhan, Jaya Prakash [Downloadable!]
  • 2008 Regulation, generic competition and pharmaceutical prices: Theory and evidence from a natural experiment
    by Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume [Downloadable!]
  • 2008 Pharmaceutical Industry, Drug Quality and Regulation: Evidence from US and Italy
    by Vincenzo Atella & Jay Bhattacharya & Lorenzo Carbonari [Downloadable!]
  • 2008 Effects of Regulation on Drug Launch and Pricing in Interdependent Markets
    by Patricia M. Danzon & Andrew J. Epstein [Downloadable!]
  • 2008 Drug price setting and regulation in France
    by Nathalie Grandfils [Downloadable!]
  • 2008 Genetic Codes of Mergers, Post Merger Technology Evolution and Why Mergers Fail
    by Alexander Cuntz [Downloadable!]
  • 2008 Generic Substitution
    by Furu, Kari & Dalen, Dag Morten & Locatelli, Marilena & Strøm, Steinar [Downloadable!]
  • 2008 Multinationals in the Knowledge Economy - a case study of AstraZeneca in Sweden
    by Andersson, Martin & Johansson, Börje & Karlsson, Charlie & Lööf, Hans [Downloadable!]
  • 2008 The European Socio-Economic Models of a Knowledge-based society. \r\nMain findings and conclusion \r\n
    by Bruno AMABLE (Université Paris I and CEPREMAP) & Yannick LUNG (GREThA UMR CNRS 5113 and GERPISA) [Downloadable!]
  • 2008 The European Socio-Economic Models of a Knowledge-based society. Main findings and conclusions
    by Bruno AMABLE (Université Paris I and CEPREMAP) & Yannick LUNG (GREThA-GRES) [Downloadable!]
  • 2008 Intellectual property rights in agricultural and agro-food biotechnologies to 2030 (© OECD International Futures Programme)
    by Trommetter, M. [Downloadable!]
  • 2008 On the Effects of Suggested Prices in Gasoline Markets
    by Riemer P. Faber & Maarten C.W. Janssen [Downloadable!]
  • 2008 Pharmaceutical Research Strategies
    by Sandra Phlippen & An Vermeersch [Downloadable!]
  • 2008 Do Auctions and Forced Divestitutes increase Competition?
    by Adriaan R. Soetevent & Marco A. Haan & Pim Heijnen
  • 2008 Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s
    by Athreye, Suma & Godley, Andrew [Downloadable!]
  • 2008 Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector
    by Athreye, Suma & Kale, Dinar & Ramani, Shyama V. [Downloadable!]
  • 2008 New Europe's Promise for Life Sciences
    by Filippov, Sergey & Kalotay, Kalman [Downloadable!]
  • 2008 Facing the Trial of Internationalizing Clinical Trials to Developing Countries: Some Evidence from Mexico
    by Santiago-Rodriguez, Fernando [Downloadable!]
  • 2008 Selbstselektion statt Personalauswahl? Auslandsentsendungen in der deutschen chemischen Industrie
    by Heiner Minssen & Susanne Schmidt [Downloadable!]
  • 2008 Advertising, Free-Riding, and Price Differences in the Market for Prescription Drugs
    by Ismo Erkki Linnosmaa [Downloadable!]
  • 2007 Exploring the relationship between scientist human capital and firm performance: The case of biomedical academic entrepreneurs in the SBIR program
    by Czarnitzki, Dirk & Toole, Andrew A. [Downloadable!]
  • 2007 Restructuring of Energy-intensive Industrial Branches in Romania and Proposals for Industrial Policy Measures
    by Gábor Hunya & Waltraut Urban & Edward Christie & Michael Landesmann & Constantin Ciupagea & Bianca Pauna & Geomina Turlea [Downloadable!]
  • 2007 Generic entry into a regulated pharmaceutical market
    by Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué [Downloadable!]
  • 2007 Multimarket Contact in Pharmaceutical Markets
    by Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín [Downloadable!]
  • 2007 The Determinants of Pricing in Pharmaceuticals: Are U.S. prices really higher than those of Canada?
    by Antonio Cabrales & Sergi Jiménez-Martín [Downloadable!]
  • 2007 Generic entry into a regulated pharmaceutical market
    by Iván Moreno Torres & Jaume Puig & Joan-Ramon Borrell-Arqué [Downloadable!]
  • 2007 Brevet, innovation modulaire et collaboration : Le cas des vaccins géniques
    by Antoine Bureth & Moritz Mueller & Julien Pénin & Sandrine Wolff [Downloadable!]
  • 2007 The Emergence of new Successful Export Activities in Uruguay
    by Michele Snoeck & Carlos Casacuberta & Rosario Domingo & Héctor Pastori & Lucía Pittaluga [Downloadable!]
  • 2007 Simulaatio lääkekehitysalan kannattavuudesta ja riskeistä
    by Raine Hermans & Martti Kulvik [Downloadable!]
  • 2007 Imposing a unilateral carbon constraint on European energy-intensive industries and its impact on their international competitiveness - data & analysis
    by Bergmann, Manfred & Schmitz, Andreas & Hayden, Mark & Kosonen, Katri [Downloadable!]
  • 2007 Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks
    by Kitsak, Maksim & Havlin, Shlomo & Paul, Gerald & Riccaboni, Massimo & Pammolli, Fabio & Stanley, H. Eugene [Downloadable!]
  • 2007 Financial Risk in the Biotechnology Industry
    by Joseph H. Golec & John A. Vernon [Downloadable!]
  • 2007 Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration
    by Glenn Ellison & Sara Fisher Ellison [Downloadable!]
  • 2007 Effects of 'Authorized-Generics' on Canadian Drug Prices
    by Paul Grootendorst [Downloadable!]
  • 2007 The Relationship among innovative Output, Productivity, and Profitability. A test comparing USPTO and EPO data
    by Enrico Santarelli & Francesca Lotti [Downloadable!]
  • 2007 Economic Policy in Health Care: Sickness Absence and Pharmaceutical Cost
    by Granlund, David [Downloadable!]
  • 2007 Consumer Information and Pharmaceutical Prices: Theory and Evidence
    by Granlund, David & Rudholm, Niklas [Downloadable!]
  • 2007 Consumer Information and Pharmaceutical Prices: Theory and Evidence
    by Granlund, David & Rudholm, Niklas [Downloadable!]
  • 2007 Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries
    by Vanessa OLTRA (GREThA) & Maïder SAINT JEAN (GREThA) [Downloadable!]
  • 2007 Incrementalism of environmental innovations versus paradigmatic change: A comparative study of the automotive and chemical industries
    by Vanessa OLTRA (GREThA-GRES) & Maïder SAINT JEAN (GREThA-GRES) [Downloadable!]
  • 2007 Flexibility in the implementation of intellectual property rights in agricultural biotechnology
    by Trommetter, M. [Downloadable!]
  • 2007 Downsizing in German Chemical Manufacturing Industry during the 1990s: Why Small Is Beautiful?
    by Oleg Badunenko [Downloadable!]
  • 2007 The strategic interaction between firms and formulary committees: Effects on the prices of new drugs
    by María García-Alonso & Begoña García-Mariñoso [Downloadable!]
  • 2007 Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?
    by Kurt R. Brekke & Astrid L. Grasdal & Tor Helge Holmås [Downloadable!]
  • 2007 Multimarket Contact in Pharmaceutical Markets
    by Javier Coronado & Sergi Jiménez-Martín & Pedro L. Marín [Downloadable!]
  • 2007 The Determinants of Pricing in Pharmaceuticals: Are U.S. Prices Really Higher than Those of Canada?
    by Antonio Cabrales & Sergi Jiménez-Martín [Downloadable!]
  • 2007 What is "Business Development"? - The Case of Biotechnology
    by Sonja Kind & Dodo zu Knyphausen-Aufseß [Downloadable!]
  • 2006 Knowledge-sourcing strategies for cross-disciplinarity in bionanotechnology
    by Isamel Rafols & Martin Meyer [Downloadable!]
  • 2006 Riskirahoituksen merkitys biotekniikka-alalla: Pääomasijoittajien vertailu yritysten näkökulmasta
    by Terttu Luukkonen & Mari Maunula [Downloadable!]
  • 2006 Adaption of New Technologies and Costs of Health Care
    by Martti Kulvik & Ismo Linnosmaa & Raine Hermans [Downloadable!]
  • 2006 `Coaching´ Small Biotech Companies into Success: The Value-adding Function of VC
    by Terttu Luukkonen & Mari Maunula [Downloadable!]
  • 2006 The Perceived Value-added of Venture Capital Investors. Evidence from Finnish Biotechnology Industry
    by Mari Maunula [Downloadable!]
  • 2006 Helsingin seudun klusterit sekä erikoistuminen bioteknologiaan ja logistiikkaan
    by Hannu Hernesniemi & Martti Kulvik [Downloadable!]
  • 2006 A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence
    by Pammolli, Fabio & Fu, Dongfeng & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene [Downloadable!]
  • 2006 A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment
    by Buldyrev, Sergey V. & Pammolli, Fabio & Riccaboni, Massimo & Yamasaki, Kazuko & Fu, Dongfeng & Matia, Kaushik & Stanley, H. Eugene [Downloadable!]
  • 2006 Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies
    by Pradhan, Jaya Prakash [Downloadable!]
  • 2006 Overseas Acquisition versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises?
    by Pradhan, Jaya Prakash & Alakshendra, Abhinav [Downloadable!]
  • 2006 Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research
    by Jeffrey L. Furman & Margaret K. Kyle & Iain M. Cockburn & Rebecca Henderson [Downloadable!]
  • 2006 Openness and Industrial Responses in a Wal-Mart World: A Case Study of Mexican Soaps, Detergents and Surfactant Producers
    by Beata Smarzynska Javorcik & Wolfgang Keller & James R. Tybout [Downloadable!]
  • 2006 Did Medicare Induce Pharmaceutical Innovation?
    by Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn [Downloadable!]
  • 2006 R&D in the Belgian Pharmaceutical Sector
    by Helga De Doncker [Downloadable!]
  • 2006 Jüngere Entwicklungen auf dem Risikokapitalmarkt für Biotechnologie in Deutschland
    by Simeon Schudy [Downloadable!]
  • 2006 Indian Patent Policy and Publich Health : implications from the Japanese Experience
    by Aoki, Reiko & Kubo, Kensuke & Yamane, Hiroko [Downloadable!]
  • 2006 The Pharmacia Story of Entrepreneurship and as a Creative Technical University - An Experiment in Innovation, Organizational Break Up and Industrial Renaissance
    by Eliasson, Gunnar & Eliasson, Åsa [Downloadable!]
  • 2006 Allocative Efficiency Measurement Revisited: Do We Really Need Input Prices?
    by Oleg Badunenko & Michael Fritsch & Andreas Stephan [Downloadable!]
  • 2006 Indian Pharma Within Global Reach?
    by Gehl Sampath, Padmashree [Downloadable!]
  • 2006 Rough Road to Market: Institutional Barriers to Innovations in Africa
    by Oyelaran-Oyeyinka, Banji & Gehl Sampath, Padmashree [Downloadable!]
  • 2006 India's product patent protection regime: Less or more of "pills for the poor"?
    by Gehl Sampath, Padmashree [Downloadable!]
  • 2006 The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan
    by Mahlich, Jörg C. & Roediger-Schluga, Thomas [Downloadable!]
  • 2006 Breaking the Fence: Patent Rights and Biomedical Innovation in 'Technology Followers'
    by Gehl Sampath, Padmashree [Downloadable!]
  • 2006 The Dye Famine and its Aftermath: Knowledge Diffusion and Entry
    by Genesove, David [Downloadable!]
  • 2006 Reference Pricing of Pharmaceuticals
    by Kurt R. Brekke & Ingrid Königbauer & Odd Rune Straume [Downloadable!]
  • 2006 La propriété intellectuelle dans les biotechnologies agricoles : quels enjeux pour quelles perspectives ?
    by Michel Trommetter [Downloadable!]
  • 2006 Comment favoriser l'innovation dans le secteur pharmaceutique : brevets et/ou récompenses ?
    by Paul Belleflamme & Tanguy van Ypersele [Downloadable!]
  • 2005 Does Public Scientific Research Complement Industry R&D Investment? The Case of NIH Supported Basic and Clinical Research and Pharmaceutical Industry R&D
    by Toole, Andrew A. [Downloadable!]
  • 2005 Public R&D Policy: The Right Turns of the Wrong Screw? The Case of the German Biotechnology Industry
    by Fier, Andreas & Heneric, Oliver [Downloadable!]
  • 2005 Functional Foods In The European Union: An Overview Of The Sector'S Main Issues
    by Alessandra CASTELLINI & Maurizio Canavari & Carlo Pirazzoli [Downloadable!]
  • 2005 Production of a New Drug: A Sequential Investment ProcessUnder Uncertainty
    by Marcello Basili & Roberto Renò & Carlo Zappia [Downloadable!]
  • 2005 Technological Characteristics and R&D Alliance Form: Evidence from the U.S. Biotechnology Industry
    by Xia Wang [Downloadable!]
  • 2005 Phases of Imitation and Innovation in a North-South Endogenous Growth Model
    by Daniel Rais & Jonathan Goldman [Downloadable!]
  • 2005 “Branded Generics” As A Strategy To Limit Cannibalization Of Pharmaceutical Markets
    by Michael R. Ward & David Reiffen [Downloadable!]
  • 2005 Innovation Paths of Estonian Biotechnology
    by Tõnis Mets [Downloadable!]
  • 2005 Consequences of the IPPC-directive’s BAT requirements for abatement costs and emissions
    by Jan Larsson and Kjetil Telle [Downloadable!]
  • 2005 The Growth of Business Firms: Theoretical Framework and Empirical Evidence
    by Fu, Dongfeng & Pammolli, Fabio & Buldyrev, Sergey V. & Riccaboni, Massimo & Matia, Kaushik & Yamasaki, Kazuko & Stanley, H. Eugene [Downloadable!]
  • 2005 Trips and Patenting Activity: Evidence from the Indian Pharmaceutical Industry
    by Alka Chadha [Downloadable!]
  • 2005 Product cycles, innovation and exports: A study of Indian pharmaceuticals
    by Alka Chadha [Downloadable!]
  • 2005 Pharmaceutical Stock Price Reactions to Price Constraint Threats and Firm-Level R&D Spending
    by Joseph Golec & Shantaram Hegde & John A. Vernon [Downloadable!]
  • 2005 Socio-economic Impact of Nanoscale Science: Initial Results and NanoBank
    by Lynne G. Zucker & Michael R. Darby [Downloadable!]
  • 2005 Parallel Imports, Drag Price Control and Pharmaceutical Innovation
    by Ken Tabata & Testuya Shinkai & Satoru Tanaka & Makoto Okamura [Downloadable!]
  • 2005 Who Develops Innovations in Medicine for the Poor? Trends in Patent Applications Related to Medicines for HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases
    by Ito, Banri & Yamagata, Tatsufumi [Downloadable!]
  • 2005 Testing Collusive Prices In A Multimarket Context: The European Case Of Vitamin C
    by Jacint Balaguer & Ezequiel Uriel Jiménez & Vicente Orts [Downloadable!]
  • 2005 Start-ups, firm growth and the consolidation of the French biotech industry
    by Avenel, E. & Corolleur, F. & Gauthier, C. & Rieu, C. [Downloadable!]
  • 2005 Knowledge and Productivity in the World's Largest Manufacturing Corporations Level:Panel Data analysis on Compustat and Patent data
    by Lionel Nesta [Downloadable!]
  • 2005 Empirical tests of optimal cognitive distance
    by Wuyts, Stefan & Colombo, Massimo G. & Dutta, Shantanu & Nooteboom, Bart [Downloadable!]
  • 2005 Density and strength of ties in innovation networks : an analysis of multi-media and biotechnology
    by Gilsing, Victor A. & Nooteboom, Bart [Downloadable!]
  • 2005 The relationship of drug reimbursement with the price and the quality of pharmaceutical innovations
    by María García-Alonso & Begoña Garcia-Mariñoso [Downloadable!]
  • 2005 Direct to Consumer Advertising in Pharmaceutical Markets
    by Kurt R. Brekke & Michael Kuhn [Downloadable!]
  • 2005 Strategic Reasons for Patenting: Between Exclusion and Coordination Rationales
    by Antoine Bureth & Rachel Levy & Julien Pénin & Sandrine Wolff [Downloadable!]
  • 2004 Biotechnology in New Zealand
    by Dan Marsh [Downloadable!]
  • 2004 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain
    by Joan Costa & Jaume Puig [Downloadable!]
  • 2004 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain
    by Joan Costa & Jaume Puig [Downloadable!]
  • 2004 Estudios de competitividad sectoriales. Industria manufacturera
    by María Inés Terra & Gustavo Bittencourt & Rosario Domingo & Carmen Estrades & Gabriel Katz & Alvaro Ons & Héctor Pastori [Downloadable!]
  • 2004 Optimal Intellectual Property Rights Protection and Humanitarian Assistance during and International Health Emergency
    by Drusilla K. Brown & George Norman [Downloadable!]
  • 2004 Persistent Knowledge Specialisation and Intra-Industry Heterogeneity: an Analysis of the Spanish Pharmaceutical Industry
    by Pablo D'Este Cukierman [Downloadable!]
  • 2004 FDI spillovers and local productivity growth: evidence from Indian pharmaceutical industry
    by Pradhan, Jaya Prakash [Downloadable!]
  • 2004 Market Structure and Drug Innovation
    by Pammolli, Fabio & Riccaboni, Massimo [Downloadable!]
  • 2004 Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure
    by Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo [Downloadable!]
  • 2004 Preferential attachment and growth dynamics in complex systems
    by Yamasaki, Kazuko & Matia, Kaushik & Buldyrev, Sergey V. & Fu, Dongfeng & Pammolli, Fabio & Riccaboni, Massimo & Stanley, H. Eugene [Downloadable!]
  • 2004 The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program
    by Frank R. Lichtenberg [Downloadable!]
  • 2004 Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
    by Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck [Downloadable!]
  • 2004 Vertical Product Differentiation, Market Entry, and Welfare
    by Reisinger, Markus [Downloadable!]
  • 2004 Competence in Health Care - An Industrial Systems Analysis Using Competence Bloc Theory to Compare European and US Health Care
    by Eliasson, Gunnar & Eliasson, Åsa [Downloadable!]
  • 2004 The Norwegian market for pharmaceuticals and the non-mandatory substitution reform of 2001: the case of enalapril
    by Razzolini, Tiziano [Downloadable!]
  • 2004 The Origin and Location of Entrants in the Evolution of the U.S. Tire Industry
    by G. Buenstorf & S. Klepper [Downloadable!]
  • 2004 A Dynamic Oligopoly Structural Model for the Prescription Drug Market After Patent Expiration
    by Andrew Ching [Downloadable!]
  • 2004 Price Regulation and Competition in Japanese Pharmaceutical Market
    by Tomofumi & Anegawa
  • 2004 Las patentes aceleran o retrasan la comercializacion de nuevos medicamentos en los paises en desarrollo?
    by Joan Ramon Borrell Arque [Downloadable!]
  • 2004 Price Competition in Pharmaceuticals: The Case of Anti-infectives
    by Steven N. Wiggins & Robert Maness [Downloadable!]
  • 2004 La gouvernance des jeunes entreprises innovantes:un éclairage analytique à partir du cas des sociétés de biotechnologies
    by Marc-Hubert Depret & Abdelillah Hamdouch [Downloadable!]
  • 2003 International Price-Fixing Cartels and Developing Countries: A Discussion of Effects and Policy Remedies
    by Margaret Levenstein & Valerie Suslow & Lynda Oswald [Downloadable!]
  • 2003 Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy
    by Antonio Cabrales [Downloadable!]
  • 2003 Pharmaceutical Generics, Vertical Product Differentiation, and Public Policy
    by Antonio Cabrales [Downloadable!]
  • 2003 Optimal Intellectual Property Rights Exhaustion and Humanitarian Assistance during a National Health Emergency
    by Drusilla K. Brown & George Norman [Downloadable!]
  • 2003 The Knowledge Bases of the World's Largest Pharmaceuticals Groups: what do Patent Citations to Non-Patent Literature Reveal?
    by Stefano Brusoni & Paola Criscuolo & Aldo Geuna [Downloadable!]
  • 2003 Intangible Assests and Market Value: Evidence from Biotechnology Firms
    by Lionel Nesta & Pier-Paolo Saviotti [Downloadable!]
  • 2003 Reverse Technology Transfer: A Patent Citation Analysis of the European Chemical and Pharmaceutical Sectors
    by Paola Criscuolo [Downloadable!]
  • 2003 The Effects of Environmental Regulation On Technology Diffusion: The Case of Chlorine Manufacturing
    by Stavins, Robert & Snyder, Lori & Miller, Nolan [Downloadable!]
  • 2003 Liberalization, Firm Size and R&D performance: A Firm Level Study of Indian Pharmaceutical Industry
    by Pradhan, Jaya Prakash [Downloadable!]
  • 2003 On Size and Growth of Business Firms
    by De Fabritiis, Gianni & Riccaboni, Massimo & Pammolli, Fabio [Downloadable!]
  • 2003 Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke: A Study of 12 OECD Countries
    by Michael Dickson & Stéphane Jacobzone [Downloadable!]
  • 2003 Uncertainty in the Generic Versus Brand Name Prescription Decision
    by Hellström, Jörgen & Rudholm, Niklas [Downloadable!]
  • 2003 Titanium Implants – A Comparison of a Swedish and an Ohio Firm
    by Fridh, Ann-Charlotte [Downloadable!]
  • 2003 The Effects of Environmental Regulation on Technology Diffusion: The Case of Chlorine Manufacturing
    by Lori Snyder & Nolan Miller & Robert Stavins [Downloadable!]
  • 2003 Globalisation and Its Impact on Competitiveness: the Case of the British and German Pharmaceutical Industry
    by Christel Lane & Jocelyn Probert [Downloadable!]
  • 2003 Reference prices: The Spanish way
    by Jorge Mestre [Downloadable!]
  • 2002 Erfolgsabhängige Vergütung: Ein sicherer Weg zur Steigerung der Leistung von Top-Managern?
    by Zwick, Thomas & Wolf, Elke & Beblo, Miriam [Downloadable!]
  • 2002 Does New Zealand have an Innovation System for Biotechnology?
    by Dan Marsh [Downloadable!]
  • 2002 Economic Insights and Deficits in European Biotechnology Patent Policy
    by Gilroy, Bernard Michael & Vollpert, Tobias [Downloadable!]
  • 2002 A Comparison of U.S. and European University-Industry Relations in the Life Sciences
    by Owen-Smith, Jason & Riccaboni, Massimo & Pammolli, Fabio & Powell, Walter W. [Downloadable!]
  • 2002 Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"
    by Frank R. Lichtenberg & Suchin Virabhak [Downloadable!]
  • 2002 Benefits and Costs of Newer Drugs: An Update
    by Frank Lichtenberg [Downloadable!]
  • 2002 Innovation and Market Structure: An Empirical Evaluation of the 'Bounds Approach' in the Chemical Industry
    by Marín Uribe, Pedro Luis & Siotis, Georges [Downloadable!]
  • 2002 Biotecnologia: corporações, financiamento da inovação e novas formas organizacionais
    by Silveira, José Maria F. J. da [Downloadable!]
  • 2001 Do court-ordered breakups spur innovation?
    by Leon Taylor [Downloadable!]
  • 2001 Modern Biotechnology in New Zealand: Further Analysis of Data from the Biotechnology Survey 1998/99
    by Dan Marsh [Downloadable!]
  • 2001 On Firm Growth in Networks
    by Riccaboni, Massimo & Pammolli, Fabio [Downloadable!]
  • 2001 An Empirical Model of Heterogeneous Consumer Search for Retail Prescription Drugs
    by Alan T. Sorensen [Downloadable!]
  • 2001 The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
    by Frank R. Lichtenberg [Downloadable!]
  • 2001 Global/local articulation in industrial models for phamaceuticals, automobile and aeronautics (In French)
    by Marie-Claude BÉLIS-BERGOUIGNAN (IFREDE-E3i) & Vincent FRIGANT (IFREDE-E3i) & Damien TALBOT (LEREPS) [Downloadable!]
  • 2001 Innovation et marche financiers: l'impact des avancees therapeutiques sur les rentabilites boursieres des firmes
    by Campart, S. & Pfister, E.
  • 2001 Research Incentives in Competing Markets: A Model of the Development of New Vaccines
    by Rey, P.
  • 2001 The World Trade Organization and Publicly Funded Healthcare in Canada
    by Ostry, A.
  • 2001 Buying Science, Selling Drugs
    by Evans, R.G. & Morgan, S.G. & Barer, M.L.
  • 2001 The Self-Organisation of Strategic Alliances
    by Andreas Pyka & Paul Windrum [Downloadable!]
  • 2001 Innovation Networks in the Biotechnology-Based Sectors
    by Andreas Pyka & Paolo Saviotti [Downloadable!]
  • 2000 Fostering Innovation in a Small Open Economy: The Case of the New Zealand Biotechnology Sector
    by Dan Marsh [Downloadable!]
  • 2000 Heterogeneity in Returns to Scale: A Random Coefficient Analysis with Unbalanced Panel Data
    by Erik Biørn, Kjersti-Gro Lindquist and Terje Skjerpen [Downloadable!]
  • 2000 The Nature and the Extent of the Market for Technology in Biopharmaceuticals
    by Arora, Ashish & Gambardella, Alfonso & Pammolli, Fabio & Riccaboni, Massimo [Downloadable!]
  • 2000 Global Competitiveness in Pharmaceuticals: A European Perspective
    by Gambardella, Alfonso & Orsenigo, Luigi & Pammolli, Fabio [Downloadable!]
  • 2000 Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
    by Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay [Downloadable!]
  • 2000 Entry and the Number of firms in the Swedish Pharmaceuticals Market
    by Rudholm, Niklas [Downloadable!]
  • 2000 How to win Schumpeterian Competition. Technological Transfers in the German Plastics Industry from the 1930s to the 1970s
    by Streb, J.
  • 2000 How to win Schumpeterian Competition. Technological Transfers in the German Plastics Industry from the 1930s to the 1970s
    by Streb, J.
  • 2000 Heternenous Labor Demand and Aggregate Job Flows. Specification, Estimation and Testing with French Data
    by Fairise, X. & Feve, P.
  • 2000 L'utilisation des notions de confiance et de proximite dans l'etude des processus de R&D pharmaceutiques
    by Perrochon, D. & Lebert, D.
  • 2000 Coalitions industrielles, reseaux de firmes et dynamiques de concurrence-cooperation dans les secteurs en cours de globalisation : le cas de l'industrie pharmaceutique
    by Hamdouch, A. & Depret, M.-H.
  • 2000 Towards a History Friendly Model of Innovation, Market Structure and Regulation in the Dynamics of the Pharmaceutical Industry: the Age of Random Screening
    by Franco Malerba & Luigi Orsenigo [Downloadable!]
  • 2000 Corporate Governance and the Governance of Innovation: the Case of Pharmaceutical Industry
    by Nicola Lacetera [Downloadable!]
  • 2000 The determinants of pharmaceutical research and development expenditures
    by Henry Grabowski & John Vernon [Downloadable!]
  • 1999 An Examination of Technology Strategies for the Integration of Bioinformatics in Pharmaceutical R&D Processes
    by Michael M. Hopkins [Downloadable!]
  • 1999 Network Effects and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
    by Ernst R. Berndt & Robert S. Pindyck & Pierre Azoulay [Downloadable!]
  • 1999 How to Win Schumpeterian Competition: Technological Transfers in the German Plastics Industry from the 1930s to the 1970s
    by Jochen Streb [Downloadable!]
  • 1998 Demand for Prescription Drugs: The Effects of Managed Care Pharmacy Benefits
    by Rika Onishi Mortimer [Downloadable!]
  • 1998 Characterizing Informational Barriers To Entry In The Anti-Ulcer Drug Market
    by Matthew Shum [Downloadable!]
  • 1998 Random Coefficients and Unbalanced Panels: An Application on Data from Norwegian Chemical Plants
    by Erik Biørn, Kjersti-Gro Lindquist and [Downloadable!]
  • 1998 The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?
    by Jean O. Lanjouw [Downloadable!]
  • 1998 The Impact of Generic Competition on Brand Name Market Shares - Evidence from Micro Data
    by Aronsson, Thomas & Bergman, Mats & Rudholm, Niklas [Downloadable!]
  • 1998 The Impact of Generic Competition on Brand Name Market Shares: Evidence from Micro Data
    by Aronsson, Thomas & Bergman, Mats A. & Rudholm, Niklas [Downloadable!]
  • 1998 Evolutionary innovations: learning, entrepreneurship and the dynamics of the firm
    by Maureen McKelvey [Downloadable!]
  • 1997 The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules
    by Fiona M. Scott Morton [Downloadable!]
  • 1997 Royalty rates, sub licensing considerations and joint ventures
    by Elli Malki [Downloadable!]
  • 1997 The economic sense of royalty rates
    by Elli Malki [Downloadable!]
  • 1997 Intellectual property and the valuation of biotechnology
    by Elli Malki [Downloadable!]
  • 1997 Entry Decisions in the Generic Pharmaceutical Industry
    by Fiona M. Scott Morton [Downloadable!]
  • 1997 The Objectives of the FDA's Office of Generic Drugs
    by Fiona Scott Morton [Downloadable!]
  • 1997 Foreign Direct Investment, Technological Capabilities and Performance in the Chinese Pharmaceutical Industry
    by White, S. & Liu X. & Yoshihara, H.
  • 1997 Organizational Dynamics and Strcuture in the Chinese Pharmaceutical Industry: A Technological System Perspective
    by White, S.
  • 1997 Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry
    by Liu, X. & White, S.
  • 1997 Outsourcing of Research by Pharmaceutical and Biotechnology Firms
    by Tapon, F. & Thong, M.
  • 1997 The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?
    by Lanjouw, J.O.
  • 1997 The Pharmaceutical Industry in India and Hungary. Policies, Institutions, and Technological Development
    by Felker, G. & Chaudhuri, S. & Gyorgy, K. & Goldman, M.
  • 1997 Medicinal Plants, Rescuing Global Heritage
    by Lambert, J. & Srivastava, J. & Vietmeyer, N.
  • 1997 Foreign Direct Investment, Technological Capabilities and Performance in the Chinese Pharmaceutical Industry
    by White, S. & Liu X. & Yoshihara, H.
  • 1997 Organizational Dynamics and Strcuture in the Chinese Pharmaceutical Industry: A Technological System Perspective
    by White, S.
  • 1997 Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry
    by Liu, X. & White, S.
  • 1997 Les prestataires logistiques et la distribution pharmaceutique. Les barrieres a l'entree: vitres blindees ou glaces sans tain
    by Mattiuzzo, N. & Le Goff, J.
  • 1997 Merger, Retionalisation and the "High Commitment" Organisation
    by Randle, K.
  • 1997 Outsourcing of Research by Pharmaceutical and Biotechnology Firms
    by Tapon, F. & Thong, M.
  • 1997 Israel: Secteur de l'equipement medical
    by Theriault, V.
  • 1997 Chili:Secteur de l'equipement medical
    by Froissart, S.
  • 1997 Belgique: Secteur de l'equipement medical haute technologie
    by Froissart, S.
  • 1997 Thailande: Secteur de l'equipement medical
    by Froissart, S.
  • 1997 Malaisie: Secteur de l'equipement medical de haute technologie
    by Froissart, S.
  • 1996 Rewarding Failure: Performance Related Pay in a Pharmaceutical research and Development Company
    by Randle, K.
  • 1995 Generics and New Goods in Pharmaceutical Price Indexes
    by Zvi Griliches & Iain Cockburn [Downloadable!]
  • 1995 R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry
    by Joseph A. Dimasi & Grabowski, Henry G. & Vernon, John
  • 1995 Do Other Firms Matter in Oligopolies?
    by Haskel, Jonathan & Scaramozzino, Pasquale [Downloadable!]
  • 1995 Genotyping by Combinatorial Optimization Techniques
    by Lancia, G.
  • 1995 The transmission of information in the transacting of primary products: the case of quality improvement in Thailand's natural rubber production
    by Shigetomi, Shinichi [Downloadable!]
  • 1994 Fast Growing Small Entrepreneurial Firms and their Venture Capital Backers: an Applied Principal-Agent Analysis
    by Gavin C Reid [Downloadable!]
  • 1994 The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry
    by Ernst R. Berndt & Linda Bui & David Reiley & Glen Urban [Downloadable!]
  • 1993 Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry
    by Rebecca Henderson & Iain Cockburn [Downloadable!]
  • Direct-to-Consumer Advertising in Pharmaceutical Markets
    by Kurt R Brekke & Michael Kuhn [Downloadable!]

    This page was last updated on 2009-11-8.


    This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.